Amicus Therapeutics
FOLD
#3908
Rank
NZ$5.28 B
Marketcap
NZ$17.14
Share price
-0.50%
Change (1 day)
3.28%
Change (1 year)

Amicus Therapeutics (FOLD) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$1.50 Billion

According to Amicus Therapeutics 's latest financial reports the company's total assets are NZ$1.50 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Amicus Therapeutics - Total assets on balance sheet (from 2005 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$1.39 B13.16%
2023-12-31NZ$1.23 B7.84%
2022-12-31NZ$1.14 B-13.93%
2021-12-31NZ$1.32 B7.86%
2020-12-31NZ$1.22 B-2.67%
2019-12-31NZ$1.26 B7.2%
2018-12-31NZ$1.17 B33.39%
2017-12-31NZ$0.88 B-41.02%
2016-12-31NZ$1.49 B12.78%
2015-12-31NZ$1.32 B395.27%
2014-12-31NZ$0.26 B72.63%
2013-12-31NZ$0.15 B16%
2012-12-31NZ$0.13 B49.64%
2011-12-31NZ$89.42 M-38.7%
2010-12-31NZ$0.14 B24.12%
2009-12-31NZ$0.11 B-47.03%
2008-12-31NZ$0.22 B1.72%
2007-12-31NZ$0.21 B157.66%
2006-12-31NZ$84.66 M101.84%
2005-12-31NZ$41.94 M
2003-12-31NZ$0.77 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Biogen
BIIB
NZ$50.55 B 3,261.78%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$13.18 B 776.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.63 B-58.10%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$142.73 B 9,391.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
NZ$0.35 B-76.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$139.43 B 9,171.80%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark